Here are relevant reports on : music-streaming-market

• Micro Mobile Data Center Market by Solution (IT, Power, Cooling Modules), Rack Unit (Up to 20 RU, 21 RU to 40 RU, above 40 RU), Form Factor (Containerized, Rack-mounted, Wall-mounted Micro Data Centers), Type (Indoor, Outdoor) - Global Forecast to 2029

  The micro mobile data center market is projected to reach USD 9.6 billion by 2029, at a CAGR of 13.3% during the forecast period. Some of the key players operating in the micro mobile data center market are – Schneider Electric (France), HPE(US), Dell(US), Vertiv(US), Huawei(China), Eaton(Ireland), IBM(US), Rittal (Germany), Panduit(US), and Stulz(Germany).

  • Published: May 2024
  • Price: $ 7150
  • TOC Available:

• Mobile Accelerator Market (Web/Content, Network, Application, Device) Global Advancements, Business Models, Technology Roadmap, Forecasts & Analysis (2012 – 2018)

  Mobile Acceleration is the process of increasing the access speed to the applications on a mobile phone. Applications may include online transactions, online games, VoIP calls etc. The mobile acceleration provides better user experience, increased revenues and reduced complexity. The challenges for the technology are to reduce excess data transfer, TCP overhead, slash too many round trips and enable faster and more secure connections.

  • Published: December 2012
  • Price: $ 4950
  • TOC Available:

• Molecular Diagnostics Market by Product & Service (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), and Application (Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)) - Global Forecast to 2030

  The global molecular diagnostics market, valued at US$18.29 billion in 2024, stood at US$19.48 billion in 2025 and is projected to advance at a resilient CAGR of 9.6% from 2025 to 2030, culminating in a forecasted valuation of US$30.74 billion by the end of the period. The Asia Pacific market is projected to register the highest CAGR during the forecast period, primarily due to the increasing healthcare expenditure and rapid expansion of medical infrastructure in Asia Pacific countries.

  • Published: August 2025
  • Price: $ 4950
  • TOC Available:

• Wireless Chipsets (Wi-Fi/WLAN, Wireless Display/Video (HD & WHDI), Mobile WiMAX & LTE (4G), ZigBee, 802.11, 802.15.4 & 802.16) Market in Consumer Electronics & Automation Applications, Global Forecast & Analysis (2012 – 2017)

  This report, based on the extensive research study of the wireless chipsets market and the related wireless semiconductor industries, is aimed at identifying the entire market of specifically the Wi-Fi/WLAN chipsets, Wireless Display/Video chipsets, Mobile WiMAX & LTE chipsets and ZigBee chipsets in Consumer and Automation applications.

  • Published: October 2012
  • Price: $ 4950
  • TOC Available:

• Fluidized Bed Combustion Boiler Market by Product Type, Applications and Geography – Market Estimates up to 2017

  Fluidized Bed Combustion (FBC) is a green technology wherein low-grade hydrocarbons are burnt to extract energy. The FBC boiler can burn coal with less emission compared with other boilers and has ability to burn variety of fuels like high ash coal, coal mine waste, biomass, petroleum coke, and even mixture of different fuels.

  • Published: March 2026
  • Price: $ 4950
  • TOC Available:

• Autologous Stem Cell & Non-stem Cell Therapies Market by Type (CAR-T, Tumor Infiltrating Lymphocyte), Indication (Cancer, Musculoskeletal, Dermatology), Source (T-Cells, Mesenchymal Stem Cell), End User (Hospital) & Region - Global Forecast to 2029

  The global autologous stem cell & non-stem cell therapies market, valued at US$3.9 billion in 2023, stood at US$5.5 billion in 2024 and is projected to advance at a resilient CAGR of 32.3% from 2024 to 2029, culminating in a forecasted valuation of US$22.2 billion by the end of the period. The major factors driving the growth of this market are the rising regulatory approvals for autologous CAR T cell therapies, increasing R&D investments in autologous therapeutics, and growing demand for personalized medicines.

  • Published: June 2024
  • Price: $ 4950
  • TOC Available:

• Biosimulation Market by Offering (Module, Integrated Platform), Application (Disease Modeling, PBPK, PKPD, Trial Simulation, Manufacturing & Supply chain: planning & forecasting), Indication (Cancer, CNS, CVS), End User, & Region - Global Forecast to 2029

  The global biosimulation market, valued at US$3.64 billion in 2023, stood at US$4.24 billion in 2024 and is projected to advance at a resilient CAGR of 16.7% from 2024 to 2029, culminating in a forecasted valuation of US$9.18 billion by the end of the period. The major factors driving the growth of this market include the high rate of clinical trial failures, the increasing necessity to predict drug pharmacokinetics and pharmacodynamics, and the importance of toxicity management.

  • Published: January 2025
  • Price: $ 4950
  • TOC Available:

• Isothermal Nucleic Acid Amplification Technology Market by Product (Assay, System), Technology (LAMP, SDA, NASBA, NEAR, HDA), Application (Diagnostics (Influenza, Hepatitis, CT/NG, COVID-19), blood screening), End User & Region - Global Forecast to 2028

  The global isothermal nucleic acid amplification technology market, stood at US$4.4 billion in 2023 and is projected to advance at a resilient CAGR of 9.2% from 2023 to 2028, culminating in a forecasted valuation of US$6.8 billion by the end of the period. The growth of the market is attributed to the cost-benefits of INAAT, rising prevalence of infectious diseases, and increasing number of blood transfusions and donations.

  • Published: March 2023
  • Price: $ 4950
  • TOC Available:

• Smart Pills Market by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), Target Area (Esophagus, Small Intestine, Large Intestine, Stomach), End User (Hospitals, Diagnostic Centers), and Region - Global Forecast to 2030

  The global smart pills market, valued at US$0.61 billion in 2023, stood at US$0.69 billion in 2024 and is projected to advance at a resilient CAGR of 11.2% from 2024 to 2030, culminating in a forecasted valuation of US$1.30 billion by the end of the period. The key factors driving the market growth include technological advancements and innovative healthcare developments.

  • Published: March 2025
  • Price: $ 4950
  • TOC Available:

• Preclinical Imaging Market by Product (Optical Imaging (Bioluminescence), Nuclear Imaging (PET, SPECT), MRI, Reagents (Luciferins, Infrared Dyes), Software), Application (Onco, Cardio), End User (Pharma, Biotech, Academic, CRO) - Global Forecast to 2030

  The global preclinical imaging market, valued at US$3.36 billion in 2024, stood at US$3.53 billion in 2025 and is projected to advance at a resilient CAGR of 4.5% from 2024 to 2030, culminating in a forecasted valuation of US$4.39 billion by the end of the period.

  • Published: December 2025
  • Price: $ 4950
  • TOC Available:

• FIRST
• PREVIOUS

Records 41 to 50 of 50